Background: The advent of genetically engineered pig production has revealed a wide array of
ZsGreen1 was most abundant in the salivary gland, moderately produced in the esophagus and levels were lowest in the stomach. Interestingly, abundance of ZsGreen1 also differed within organ. For instance, levels were highest in the right ventricle compared with other chambers of the heart. There was no effect of transgene dose as ZsGreen1 expression patterns were similar between 25 homozygous and hemizygous piglets.
Conclusions:
Ultimately, these results elucidate the tissue-specific activity of the CMV promoter in the neonatal pig. Moreover, this model can serve as a useful tool for research applications requiring reporter gene activity in mammalian organs. 30
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Background
Use of genetically engineered pig models has grown dramatically in recent years [1] . Transgenic swine are increasingly being utilized as animal models for human disease since they are 35 anatomically, physiologically and phylogenetically more similar to humans than rodents [1, 2] .
Consequently, successful xenotransplantation of transgenic pig organs to humans is eminent [3] .
In addition to biomedical applications, genetically engineered pigs are also being developed to better understand porcine physiology and enhance the agricultural industry [4] [5] [6] [7] .
The first genetically engineered pig was generated in an effort to enhance growth rates and 40 harbored a transgene containing the mouse metallothionein-I promoter fused to the human growth hormone gene [8] . Since then, new methodologies (e.g., homologous recombination, gene editing) have enhanced the ease and efficiency of modifying the pig genome [9] . However, incorporation of a transgene remains a prominent method to produce genetically engineered pigs [1] . The most critical aspect of transgenic animal production is promoter selection [10] . Depending on the 45 research interest and application, promoter types include tissue-specific, cell-specific, inducible/conditional or ubiquitous [10] . Since ubiquitous promoters drive transgene expression in all tissues, they are a popular choice to address whole-body questions [10] .
The human cytomegalovirus (CMV) immediate early promoter is one example of a ubiquitous promoter. It was discovered by Boshart et al. [11] and has since been heavily utilized 50 to drive recombinant gene expression due to its constitutive and promiscuous nature [12] . These characteristics are directly related to its role in viral infection. Cytomegalovirus is a human herpesvirus which typically lays dormant in infected host cells [13] . Cellular infection quickly (< 1 h) leads to CMV gene expression via the interaction of host transcription factors with the CMV promoter [13] . Gene products of this initial interaction mediate the activation of other promoters 55 within the CMV genome that facilitate virus replication and invasion [13] . Therefore, the CMV promoter has evolved to contain binding sites for many ubiquitous transcription factors in order to replicate in a broad range of host cells [12] . This discovery has had a major impact on the scientific community; the CMV promoter is now the most commonly used ubiquitous promoter and it is also considered the most robust [14] . 60 The CMV promoter has been utilized to drive transgene expression in numerous vertebrate animal models including: sheep [15] [16] [17] , fish [14, 18] , mice [19] [20] [21] [22] , rats [23, 24] , chickens [25] and pigs [4, [26] [27] [28] . In the pig, the CMV promoter was used to drive expression of green fluorescent protein (GFP) [27] . As anticipated, expression of the transgene was detected in a wide range of organs, including those derived from each of the 3 germ layers: skin (ectoderm), pancreas 65 (endoderm), and kidney (mesoderm). Despite apparent universal transgene expression [27] , the CMV promoter was preferentially active in exocrine vs. non-exocrine cells of the pig [26] . Given the growing interest in the development of transgenic swine models, the objective of this study was to quantify activity of the CMV promoter in a wide range of porcine tissues.
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Methods
Animals
All animal procedures were conducted in accordance with the University of Nebraska-Lincoln (UNL) Institutional Animal Care and Use Committee. Experiments were performed in the UNL Animal Science Building (Lincoln, NE) and utilized transgenic swine that express ZsGreen1 75 controlled by the human CMV immediate early promoter; these animals were generated as previously described [4] . In hemizygous animals, one copy of the CMV-ZsGreen1 transgene is stably integrated on chromosome 14 [4] , and has remained transcriptionally active throughout the lifetime of the founder animal and in 10 subsequent generations.
Adult animals were housed individually with ad libitum access to water and fed 80 approximately 2.5 kg of feed daily. Hemizygous CMV-ZsGreen1 transgenic sows were artificially inseminated with semen from non-littermate hemizygous transgenic boars and allowed to gestate to term. Following Mendelian inheritance, these matings yielded hemizygous, homozygous (2 copies of the transgene), and non-transgenic (control) littermates. After farrowing, piglets remained with their dam to suckle ad libitum. 85
At 1 d of age, 3 littermate female piglets (control, hemizygous transgenic and homozygous transgenic) were selected from 3 different litters; each litter was produced from a different dam and sire mating to maximize genetic diversity. Initially, transgene status was assessed via evaluation of ZsGreen1 expression using an ultraviolet (UV) light and a Roscolux #15 filter (deep straw; Rosco, Port Chester, NY). 90
Tissue collection
Piglets were euthanized via intracardiac injection with Euthasol (1 mL/4.53 kg BW; Delmarva Laboratories, Midlothian, VA) and stored at 4°C overnight prior to dissection. The following morning, 35 organ samples generally representing 5 anatomical regions (brain, thoracic, digestive, 95 renal and reproductive) were collected from each transgenic piglet. Isolated tissues included: cerebrum, cerebellum, spinal cord, anterior pituitary gland, posterior pituitary gland, hypothalamus, thymus, lymph node, the four chambers of the heart, lung, muscle, thyroid, salivary gland, esophagus, stomach, duodenum, jejunum, ileum, colon, gall bladder, spleen, pancreas, liver, kidney (medulla and cortex), bladder, adrenal gland (medulla and cortex), ovary, uterus, oviduct, 100 and skin. Skin samples were collected from control littermate piglets to serve as a negative control for ZsGreen1 immunoblotting. In addition, tail samples were collected from all piglets for genotyping. All samples were frozen and stored at -80°C until analysis.
Deoxyribonucleic acid extraction 105
Genomic deoxyribonucleic acid (DNA) was isolated from tail samples using an enzymatic 
Genotyping 115
Since the transgene integration site was previously identified in this model [4] , copy number was evaluated via conventional polymerase chain reaction (PCR) using 3 primers. The forward (F) and reverse (R) primers were designed to flank the insertion site of the transgene (T) and an additional reverse primer (RT) aligning the transgene was included (F -GCA ACC TCT TCG ACA CTC CA; R -AGC TAC CAG GGA ACA AAG CC; RT -GGT TTC CCT TTC GCT TTC AAG T). products were subjected to electrophoresis on a 1% agarose gel. Products generated from the F and R primer pair were 627 bp in length and reflected a wild type chromosome 14. Products from the F and RT primer pair resulted in an 847 bp product, and indicating that the transgene was present.
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Protein preparation
Protein extraction and sample preparation was performed as described previously [29] . Protein was extracted by homogenization of tissue samples in radioimmunoprecipitation assay (RIPA) buffer (1 ml/100 mg; 20 mM Tris, 137 mM NaCl, 10% glycerol, 1% NP40, 0.1% SDS, 0.5% 
Quantification of ZsGreen1 abundance
Blots were scanned on an Odyssey Infrared Imager (700 channel; intensity 5.0; 169 micron resolution; LI-COR Biosciences) and converted to greyscale for analysis. Band density was 160 quantitated with Odyssey imaging software (version 2.1; LI-COR Biosciences). Since the abundance of common loading controls (e.g., β-actin) differs across tissue types, total protein levels within each lane were used as the loading control according to Eaton et al. [30] . After ZsGreen1 imaging, membranes were stained with GelCode Blue Safe Protein Stain (ThermoScientific, Rockford, IL) for approximately 1 h and then rinsed with a 50% methanol and 165 1% acetic acid solution for 1 h. Blots were reimaged (700 channel; intensity 1.0; 169 micron resolution; LI-COR Biosciences), converted to greyscale and quantitated using Odyssey imaging software (version 2.1; LI-COR Biosciences) to determine the relative quantity of protein present in each sample. Data are presented as the relative band density of ZsGreen1 normalized by the total protein levels within the entire lane as described previously [30] . 170
Statistical Analysis
Analyses were performed using the Statistical Analysis System (SAS; Cary, NC; version 9.4).
Analysis of variance (ANOVA) was performed via the MIXED procedure of SAS with tissue type as the fixed effect. Blot and litter were random effects. P < 0.05 was considered significant, 175 whereas P < 0.10 was considered a tendency. Results are presented as least squares means (LSMEANS) ± the standard error of the mean (SEM). No effect of genotype (hemizygous versus homozygous) on ZsGreen1 abundance was observed (P > 0.10).
Results
180
Identification of hemizygous and homozygous CMV-ZsGreen1 transgenic piglets
Presence of ZsGreen1 in the skin of neonatal transgenic piglets was detected visually ( Figure 1A) and via immunoblot ( Figure 1B) , indicative of CMV promoter activity. Even without the UV light, transgenic animals were identifiable via the yellow hue of their skin (data not shown), which has been previously noted in GFP pigs [26] . The genotype of the animals was confirmed by 185 conventional PCR ( Figure 1D ); a schematic depicting the genotyping method is available in Figure   1C . ZsGreen1 was not detected in the skin of control piglets ( Figure 1A & 1B). 
ZsGreen1 fluorescence within tissues of CMV-ZsGreen1 transgenic piglets
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Abundance of ZsGreen1 in hemizygous and homozygous porcine organs
Neural and endocrine tissues of the brain
There was an effect of tissue type on ZsGreen1 production levels within the brain and nervous system of hemizygous piglets (P = 0.0002). Abundance of ZsGreen1 was greatest within the anterior pituitary gland, followed by the cerebellum (P < 0.05; Figure 3A ). ZsGreen1 levels were 205 lowest in the cerebrum, spinal cord, hypothalamus and posterior pituitary gland (P < 0.05), which were not different from each other (P > 0.05; Figure 3A) . In homozygous piglets, there was also an effect of tissue type on ZsGreen1 abundance (P = 0.0396). The anterior pituitary gland expressed more ZsGreen1 than the cerebrum, spinal cord, hypothalamus or posterior pituitary gland (P < 0.05; Figure 3B ), but was not different from the cerebellum (P > 0.05; Figure 3B ). 210
ZsGreen1 levels were similar between the cerebellum, cerebrum, spinal cord, hypothalamus and posterior pituitary gland (P > 0.05; Figure 3B ).
Thoracic organs
An effect of tissue type on ZsGreen1 protein abundance was observed among 9 thoracic organs of 215 hemizygous piglets (P < 0.0001). The right ventricle produced the most ZsGreen1 in the thoracic region, even when compared with the other chambers of the heart (P < 0.05; Figure 4A ). ZsGreen1 levels in the right ventricle were greater (P < 0.05) than the thyroid, right atrium, left atrium, left ventricle, lung, thymus or lymph node, which were similar (P > 0.05; Figure 4A ). ZsGreen1 levels within skeletal muscle were intermediate (P < 0.05; Figure 4A ). In homozygous piglets, there was 220 no effect of tissue type on expression of ZsGreen1 among thoracic organs (P = 0.3326; Figure 4B ).
Although, values for ZsGreen1 abundance were numerically higher in the right ventricle and skeletal muscle compared with other tissues.
Digestive Organs 225
ZsGreen1 protein levels differed across 11 digestive organs of hemizygous piglets (P < 0.0001).
Levels were greatest in the salivary gland and lowest in the stomach, pancreas, duodenum, jejunum, ileum, colon, spleen, gall bladder, and liver, which were not different (P > 0.10). Protein amounts were intermediate in the esophagus (P < 0.05; Figure 5A ), with the exception of the duodenum which was similar (P > 0.05). In homozygous piglets, there was also an effect of tissue 230 type on ZsGreen1 protein abundance (P = 0.0212). Expression was greatest in the salivary gland (P < 0.05; Figure 5B ) compared with the other 10 organs, which were similar (P > 0.05; Figure   5B ).
Renal Organs 235
An effect of tissue type was observed between 5 renal tissues of hemizygous piglets (P = 0.0083).
The adrenal medulla produced more ZsGreen1 than the adrenal cortex, kidney medulla, kidney cortex or bladder (P < 0.05; Figure 6A ), which were similar to each other (P > 0.05). In homozygous animals, there tended to be a difference in ZsGreen1 abundance across renal tissues (P = 0.0620). Levels were highest in the adrenal medulla and lowest in the kidney medulla, kidney 240 cortex, and bladder (P < 0.05; Figure 6B ), which were not different from one another (P > 0.05).
ZsGreen1 levels were similar between the adrenal cortex and all other organs (P > 0.05; Figure   6B ).
Reproductive organs 245
No differences in ZsGreen1 expression were detected between the ovary, oviduct, and uterus of hemizygous or homozygous piglets (P > 0.05; Figure 7A and 7B).
Discussion
Our study provides a quantitative, spatial analysis of tissue-specific ZsGreen1 protein 250 abundance in swine containing a CMV-ZsGreen1 transgene. In accord with the ubiquitous nature of the CMV promoter, ZsGreen1 protein was detected in every tissue examined via immunoblotting. Consistent with this, another report from our laboratory indicated that exosomes isolated from the milk of hemizygous females are labeled with ZsGreen1 [31] . Our results, however, demonstrate that the level of CMV promoter activity was variable across organs of the 255 neonatal piglet. Others have observed similar results in different animal models expressing a transgene driven by the CMV promoter [14, 25, 26, 32] . Based upon these results, several hypotheses regarding the differential activity of the CMV promoter in vivo have arisen. The activity of the CMV promoter within a given cell type may be influenced by integration site [32] ;
namely, CMV promoter activation may only occur in transcriptionally active regions of the 260 genome [12] . Stochastic silencing can occur when a transgene is integrated near a heterochromatic region, such as a centromere [33] , rendering the promoter inaccessible to transcriptional machinery [34] . Stochastic silencing of transgenes can also occur when multiple copies of the transgene integrate in tandem [35] , due to local formation of heterochromatin [34] . In support of this hypothesis, Furth et al. [32] observed that two different transgenic mouse lines had marked 265 differences in CMV promoter activity across tissues of the body, despite harboring the same transgene. Likewise, transgenic animals harboring a transgene, but lacking expression of the gene, have been generated [36] . These results could also be due to promoter methylation, which has been shown to silence transgenes in vitro and in vivo [15, 16, 21, 37] . Conversely, Vasey et al. (2009) hypothesized that integration site does not readily affect CMV promoter activity because a similar 270 activity profile was detected in pigs and chickens harboring the same transgene, albeit integrated in different chromosomal regions [26, 27] . The activity patterns were also similar in multiple transgenic chicken lines expressing different reporter genes directed by the CMV promoter [25] .
Our data support these results as a similar expression pattern was observed in CMV-ZsGreen1 pigs, despite a different integration site and transgene. 275
In addition to chromatin status, the repertoire of transcription factors and co-regulators present within the cell dictate CMV promoter activity [12] . Mella-Alvarado et al. (2013) hypothesized that CMV promoter activity is robust in the organs that CMV infects most voraciously (brain, eye, spinal cord, pancreas, kidney, testis, ovary, skin, cartilage, and skeletal muscle), reflective of optimal transcription factor expression. Moreover, Furth et al. [32] suggested 280 that certain transcription factors may only be able to interact with euchromatin, whereas others retain functionality with heterochromatin [32] . In exocrine glands, Vasey et al. [26] proposed that the transcription factor, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), is a major driver of CMV promoter activity. NF-kB is highly expressed in exocrine cells, classically regulates the expression of proinflammatory genes [38] , activates in response to cellular insult 285 such as viral infection [38] , and is a potent regulator of the CMV promoter [12, [39] [40] [41] . In addition to NF-kB, numerous transcription factors have been implicated in the regulation of the CMV promoter, including ying yang 1 [12] , activator protein 1 and its major subunits (c-Fos and c-Jun)
[41], p53, cAMP response element binding nuclear transcription factor/activating transcription factor, retinoic acid receptor [42] , specificity protein 1 [11], nuclear factor I, serum response factor, 290
Elk-1 and CCAAT/enhancer-binding protein [13] . Thus, it is apparent that the CMV promoter has adapted to respond to a variety of cell signals in order to allow for the promiscuous infection of host cells [12] .
Consistent with elevated activity of the CMV promoter in exocrine glands, ZsGreen1 protein levels were increased in the salivary glands of hemizygous and homozygous transgenic 295 piglets, as previously noted in CMV-GFP pigs [26] . Enhanced CMV promoter activity was reported in other exocrine tissues of the pig, including the glandular epithelia of the snout, sebaceous glands of the skin and Harderian gland of the eye [26] . In the exocrine pancreas, however, we did not detect elevated ZsGreen1 levels in either hemizygous or homozygous transgenic piglets, conflicting with other reports of increased CMV promoter activity within the 300 porcine pancreas [26, 27] . This discrepancy could be related to age-specific activity levels of the CMV promoter, as noted in zebrafish [14] . In the current study, neonatal (1 d old) piglets were utilized, whereas others examined CMV promoter activity in the pancreases of older (2 mo to 1 yr) pigs [26, 27] . Likewise, our laboratory detected robust ZsGreen1 abundance in the pancreas of 1 mo old piglets (unpublished data). Interestingly, the exocrine pancreas is largely quiescent in the 305 neonatal piglet [43] [44] [45] [46] [47] ; production of pancreatic juices and enzymes increase dramatically after weaning [43] [44] [45] . In the liver, another exocrine organ that secretes bile made by hepatocytes [48], we also detected little CMV promoter activity. Others have reported similar levels of CMV promoter activity in porcine hepatocytes [26] and chicken liver [25] . In contrast, GFP was robustly driven by the CMV promoter in hepatocytes of zebrafish [14] . Thus, it appears that the CMV 310 promoter is not uniformly effective in all exocrine organs and can vary in activity across species.
In the current study, abundance of ZsGreen1 was also compared between homozygous and hemizygous animals. Based on our visual observation of ZsGreen1 production in the skin of hemizygous and homozygous piglets ( Figure 1A) , we hypothesized that an additional transgene would yield more ZsGreen1 protein in the organs of homozygous animals. However, no genotype 315 effect was detected based upon quantification of immunoblots for ZsGreen1. These results may be due to monoallelic expression, which frequently occurs in autosomes [49] and has also been described in other transgenic animal models [34, 50] . Conversely, translation of ZsGreen1 transcripts may be impaired in homozygous animals. For example, post-transcriptional silencing of high expressing transgenes is common in homozygous, but not hemizygous, plants [51] [52] [53] [54] and 320 appears to be mediated by short interfering RNA [51] . Many have hypothesized that doubling transcription of a transgene yields copious mRNA transcripts, which breaches an unknown threshold that triggers cellular processes to suppress transgene translation [52, [55] [56] [57] [58] . Regardless of the mechanism, transgene copy number did not significantly affect production of ZsGreen1 protein in this study. 325
To our knowledge, these animals represent the first pig model to express ZsGreen1 (Clontech, Palo Alto, CA). This protein, originally discovered by Matz et al. [59] , is derived from Anthozoa coral reef (Zoanthus species). The variant, ZsGreen1, is a modification of the original protein (zFP506) to maximize expression, solubility and prompt chromophore maturation (Clontech, personal communication). Interestingly, it is both structurally and functionally distinct 330 from other fluorescent proteins, like GFP [59, 60] . Although both fluorescent proteins are configured in a β-barrel structure [59] , ZsGreen1 exists as a tetramer, whereas GFP (derived from jellyfish) is a monomer that frequently dimerizes for solubility [61] . Interestingly, ZsGreen1 is only 26% homologous to GFP and each ZsGreen1 monomer is 231 amino acids in length with a predicted molecular weight of approximately 26 kDa [59] . Functionally, ZsGreen1 displays 335 extremely bright fluorescence and high signal-to-noise ratio; in fact, yeast cells overexpressing ZsGreen exhibited 8.6-fold more fluorescence than those expressing GFP [60] . In another study, ZsGreen1 had the greatest relative fluorescence compared with 5 other fluorescent proteins, including GFP [59] .
Notably, this ZsGreen1 swine model could serve as a useful tool for genome editing 340 applications. This model is well suited for re-engineering the transgene locus since expression of the transgene is readily detectable, the transgene is present in a single copy and the integration site has been identified [4] . For example, this swine line could be used for testing somatic cell gene editing using CRISPR/Cas9 systems or base editor nucleases by targeting the ZsGreen1 transgene sequence. In addition, the model can be a useful tool for testing germline genome editing 345 approaches in vivo such as Genome editing via Oviductal Nucleic Acids Delivery (GONAD), initially established in the mouse [62] . Finally, this pig model can be used for re-engineering the transgenic CMV-ZsGreen1 locus to make it suitable for other applications. For example, the ZsGreen1 coding sequence can be disrupted to create a frameshift mutation in ZsGreen1, creating a model to serve as a reporter for homology directed repair genome editing studies. Alternatively, 350 a floxed red fluorescent protein could be inserted upstream of the ZsGreen1 cassette to serve as a Cre recombinase reporter, similar to what is popularly used in mouse Cre-LoxP studies [63] . Re-engineering of the locus can be achieved via Easi-CRISPR, a highly efficient genome engineering method recently described in mice [64, 65] .
355
Conclusions
This study demonstrates that the CMV promoter is ubiquitously active in all porcine tissues types examined; however, the level of activity is tissue-specific. The CMV promoter potently drives transgene expression in many exocrine (e.g., salivary gland) and non-exocrine organs (e.g., skin, anterior pituitary gland and muscle) of the neonatal pig. In certain organs (e.g., liver, kidney), 360 however, activity of the CMV promoter is less robust. Ultimately, this report elucidates the tissuespecific activity of the human CMV promoter in swine and provides critical information for researchers seeking an effective promoter to drive transgene expression in the neonatal pig.
Moreover, these animals represent a novel resource for scientists in need of ZsGreen1-labeled porcine organs. Lastly, this CMV-ZsGreen1 swine model will also serve as a valuable tool to 365 advance genome editing research. 
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